X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-23 | ARVN | Houston John G | Pres, CEO | S - Sale+OE | $47.05 | -5,196 | 1,036,681 | 0% | -$244,472 | |||||
2024-02-23 | ARVN | Cassidy Sean A | CFO | S - Sale | $47.05 | -1,702 | 181,916 | -1% | -$80,079 | ||||||
| D | 2024-02-23 | ARVN | Peck Ronald | Chief Medical Officer | S - Sale+OE | $47.05 | -1,699 | 67,516 | -2% | -$79,938 | |||||
| D | 2024-02-23 | ARVN | Taylor Ian | Chief Scientific Officer | S - Sale+OE | $47.05 | -1,701 | 147,522 | -1% | -$80,032 | |||||
| D | 2023-08-11 | ARVN | Peck Ronald | Chief Medical Officer | S - Sale+OE | $24.39 | -1,324 | 29,965 | -4% | -$32,289 | |||||
| D | 2023-03-01 | ARVN | Taylor Ian | Chief Scientific Officer | S - Sale+OE | $29.53 | -1,051 | 101,721 | -1% | -$31,036 | |||||
| D | 2023-03-01 | ARVN | Houston John G | Pres, CEO | S - Sale+OE | $29.53 | -5,878 | 917,427 | -1% | -$173,577 | |||||
| D | 2023-03-01 | ARVN | Cassidy Sean A | CFO | S - Sale+OE | $29.53 | -1,745 | 183,618 | -1% | -$51,530 | |||||
| AD | 2022-08-12 | ARVN | Peck Ronald | Chief Medical Officer | S - Sale+OE | $54.84 | -1,258 | 8,154 | -13% | -$68,994 | |||||
| D | 2022-08-12 | ARVN | Peck Ronald | Chief Medical Officer | S - Sale+OE | $68.99 | -1,258 | 8,154 | -13% | -$86,794 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |